Search
Movember
PCC Homepage
Prostate Cancer
Answering Your Questions
The Basics
Testing and Diagnosis
Basics on Treatment
Treatments
Glossary
Care and Support Post-Treatment
Prostate Cancer Support
Managing Treatment Side- Effects
What Happens After Treatment?
Support Groups
Find a Group Near You
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Nova Scotia
Ontario
PEI
Quebec
Saskatchewan
Start a New Group
Contact Your Regional Rep
Add/Change Your Group Info
Join A Virtual Support Group
About the Network
Advocacy
Donate
Privacy Policy
National Conference
2011 Information
2010 Information
2009 Information
Political Action
What We Do
Mailing List
News and Announcements
Newsletters
Archived CPCN Newsletters
PCCN Barrie (Man to Man)
PCCN Brampton
PCCN Calgary
PCCN Comox Valley
PCCN Durham Region
Kelowna
PCCN Newmarket
PCCN Markham
PCCN Montreal West Island
Newfoundland & Labrador (In Touch)
PCCN Ottawa
PCCN Owen Sound
PCCN Pictou County
PCCN Regina
PCCN Surrey
PCCN Thunder Bay
PCCN Toronto
PCCN Winnipeg
Other Newsletters and Magazines
PCCN News
In The News
Well-Done Meat Consumption May Increase Prostate Cancer Risk
Research into the dietary habits of about a thousand men from the Cleveland area has found that a high consumption of meats, especially of red meat prepared by grilling, is positively associated with an increased risk of developing aggressive prostate cancer. This particular study, which was led by Dr. John Witte of the University of California, San Francisco (UCSF), has a number of limitations, but it does add support to other investigations connecting meat consumption with cancer risk.
Toronto researchers speculate regarding a link between prostate cancer and oral contraceptive use
Very preliminary and speculative research, designed to spark further inquires, suggests that there may be a connection between oral contraceptive use and rising rates of prostate cancer. One theory is that the widespread use of birth-control pills in various populations may result in a higher level of estrogen in the environment, which might, in turn, increase prostate cancer risk.
Click For Information Archive
Displaying results 36-40 (of 60)
|<
<
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
>
>|
PCCN Support Groups: A Wealth of Information
| 3/14/2011
These days, when access to multimedia resources via the Internet is so easy to arrange, PCCN support groups are finding new ways to record and distribute information. Most groups have newsletters and regular meetings, and both are excellent for addressing the current concerns and interests of members. And many groups are also providing multimedia resources. Often, these are videos of meetings that feature talks with cutting-edge researchers and practitioners.
Prostate Cancer and Bone Health
| 3/6/2011
If you are living with prostate cancer, you know that modern treatments enable many men with the disease to live long and healthy lives. That’s the wonderful news! The cautionary corollary is that it’s best to treat prostate cancer as a chronic condition. So once a man has been diagnosed with the disease, he should be vigilant about monitoring and maintaining his health. One important area for vigilance is bone health.
PCC Makes Excellent Long-Term Investment in CPC GENE
| 2/28/2011
Earlier in February, Prostate Cancer Canada (PCC) announced that it would contribute up to $15 million to a new Canadian research project --- The Canadian Prostate Cancer Genome Network (CPC GENE). CPC GENE, which aims to map the genetic structure of prostate cancer, is one of 38 other research projects funded under the International Genome Consortium (ICGC). Although this genetic mapping of prostate cancer may not yield new therapies or diagnostic tools for some years, the discoveries made by CPC GENE could be key in developing the more personalized prevention, diagnosis, and treatment strategies of the future. One need only investigate this month’s medical news headlines to see how far-sighted and well-considered PCC’s investment in genetic research is.
Dutasteride May Slow Growth of Early-Stage Prostate Cancer
| 2/21/2011
A study presented at the 2011 Genitourinary Cancers Symposium suggests that dutasteride (Avodart), a drug commonly used to treat men with enlarged prostates, may also slow the growth of tumours in men who choose to have their low-risk prostate cancer monitored through
active surveillance
. Other data from the study indicate that dutasteride also increases adherence to active surveillance by reducing anxiety about disease progression.
Network of "Clustered" Support Groups Ideal
| 2/14/2011
In today's world of online social networking, the prostate cancer support group composed of men who meet regularly face to face may seem a bit old fashioned, even if these groups also have websites, online discussion forums, or other ways of connecting via the Internet to the broader world of prostate cancer support. But research continues to show how valuable these traditional support groups are when it comes to developing the close friendships that motivate and sustain men who have been diagnosed with prostate cancer.
Displaying results 36-40 (of 60)
|<
<
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
>
>|
Twitter feed temporarily unavailable.
Follow Us On Twitter
GIVE NOW!
Ethics and Accountability
About Prostate Cancer
Prostate Cancer News
Careers
Receive updates and be the first to find out what's new at PCC.
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca
Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development
Inorbital